immunologic reconstitution despite low levels of engraftment Neonatal bone marrow transplantation of ADA-deficient SCID mice

http://bloodjournal.hematologylibrary.org/content/111/12/5745.full.html Updated information and services can be found at: (1823 articles) Transplantation • (4881 articles) Immunobiology • Articles on similar topics can be found in the following Blood collections http://bloodjournal.hematologylibrary.org/site/misc/rights.xhtml#repub_requests Information about reproducing this article in parts or in its entirety may be found online at: http://bloodjournal.hematologylibrary.org/site/misc/rights.xhtml#reprints Information about ordering reprints may be found online at: http://bloodjournal.hematologylibrary.org/site/subscriptions/index.xhtml Information about subscriptions and ASH membership may be found online at:

[1]  W. Friedrich,et al.  Hematopoietic Cell Transplantation for Immunodeficiency Diseases , 2009 .

[2]  C. Di Serio,et al.  Ex vivo gene therapy with lentiviral vectors rescues adenosine deaminase (ADA)-deficient mice and corrects their immune and metabolic defects. , 2006, Blood.

[3]  Kathryn L. Parsley,et al.  Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[4]  D. Kohn,et al.  In vivo transduction by intravenous injection of a lentiviral vector expressing human ADA into neonatal ADA gene knockout mice: a novel form of enzyme replacement therapy for ADA deficiency. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[5]  L. Notarangelo,et al.  Reduced thymic output, increased spontaneous apoptosis and oligoclonal B cells in polyethylene glycol‐adenosine deaminase‐treated patients , 2005, European journal of immunology.

[6]  K. Weinberg,et al.  Long-term efficacy of enzyme replacement therapy for adenosine deaminase (ADA)-deficient severe combined immunodeficiency (SCID). , 2005, Clinical immunology.

[7]  A. Mortellaro,et al.  Correction of ADA-SCID by Stem Cell Gene Therapy Combined with Nonmyeloablative Conditioning , 2002, Science.

[8]  L. Notarangelo,et al.  Immune reconstitution in ADA-SCID after PBL gene therapy and discontinuation of enzyme replacement , 2002, Nature Medicine.

[9]  H. Wardemann,et al.  B-1a B Cells that Link the Innate and Adaptive Immune Responses Are Lacking in the Absence of the Spleen , 2002, The Journal of experimental medicine.

[10]  A. Al-ghonaium,et al.  Adenosine deaminase deficiency with mosaicism for a "second-site suppressor" of a splicing mutation: decline in revertant T lymphocytes during enzyme replacement therapy. , 2002, Blood.

[11]  K. Yamaguchi,et al.  T-cell lines from 2 patients with adenosine deaminase (ADA) deficiency showed the restoration of ADA activity resulted from the reversion of an inherited mutation. , 2001, Blood.

[12]  M. Blackburn,et al.  The Use of Enzyme Therapy to Regulate the Metabolic and Phenotypic Consequences of Adenosine Deaminase Deficiency in Mice , 2000, The Journal of Biological Chemistry.

[13]  James J. Lee,et al.  Metabolic Consequences of Adenosine Deaminase Deficiency in Mice Are Associated with Defects in Alveogenesis, Pulmonary Inflammation, and Airway Obstruction , 2000, The Journal of experimental medicine.

[14]  P. J. Morris,et al.  Polychlorinated biphenyl mixtures (Aroclors) inhibit LPS-induced murine splenocyte proliferation in vitro. , 1999, Toxicology.

[15]  A. Fischer,et al.  Long-term chimerism and B-cell function after bone marrow transplantation in patients with severe combined immunodeficiency with B cells: A single-center study of 22 patients. , 1999, Blood.

[16]  M. Sands,et al.  Percutaneous intravenous injection in neonatal mice. , 1999, Laboratory animal science.

[17]  J. Roberts,et al.  Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. , 1999, The New England journal of medicine.

[18]  K. Weinberg,et al.  T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates , 1998, Nature Medicine.

[19]  M. Blackburn,et al.  Adenosine Deaminase-deficient Mice Generated Using a Two-stage Genetic Engineering Strategy Exhibit a Combined Immunodeficiency* , 1998, The Journal of Biological Chemistry.

[20]  D. Williams,et al.  A novel method of myeloablation to enhance engraftment of adult bone marrow cells in newborn mice. , 1996, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[21]  C. Caskey,et al.  Tissue-specific Rescue Suggests That Placental Adenosine Deaminase Is Important for Fetal Development in Mice (*) , 1995, The Journal of Biological Chemistry.

[22]  A. Berns,et al.  Adenosine–deaminase–deficient mice die perinatally and exhibit liver–cell degeneration, atelectasis and small intestinal cell death , 1995, Nature Genetics.

[23]  J. Belmont,et al.  Disruption of the adenosine deaminase gene causes hepatocellular impairment and perinatal lethality in mice. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[24]  M. V. van Tol,et al.  Relationship between patterns of engraftment in peripheral blood and immune reconstitution after allogeneic bone marrow transplantation for (severe) combined immunodeficiency. , 1994, Blood.

[25]  D. Ownby,et al.  Somatic mosaicism for a newly identified splice-site mutation in a patient with adenosine deaminase-deficient immunodeficiency and spontaneous clinical recovery. , 1994, American journal of human genetics.

[26]  W. Friedrich,et al.  Evidence for engraftment of donor-type multipotent CD34+ cells in a patient with selective T-lymphocyte reconstitution after bone marrow transplantation for B-SCID. , 1994, Blood.

[27]  K. Weinberg,et al.  T lymphocyte ontogeny in adenosine deaminase-deficient severe combined immune deficiency after treatment with polyethylene glycol-modified adenosine deaminase. , 1993, The Journal of clinical investigation.

[28]  T. Knudsen,et al.  Effects of (R)-deoxycoformycin (pentostatin) on intrauterine nucleoside catabolism and embryo viability in the pregnant mouse. , 1992, Teratology.

[29]  A. Fischer,et al.  European experience of bone-marrow transplantation for severe combined immunodeficiency , 1990, The Lancet.